Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) FCF Margin (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed FCF Margin for 2 consecutive years, with 113.49% as the latest value for Q4 2025.

  • On a quarterly basis, FCF Margin rose 3949.0% to 113.49% in Q4 2025 year-over-year; TTM through Oct 2025 was 152.91%, a 3187.0% increase, with the full-year FY2025 number at 168.09%, up 13557.0% from a year prior.
  • FCF Margin was 113.49% for Q4 2025 at Kestra Medical Technologies, up from 177.79% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 113.49% in Q4 2025 to a low of 191.96% in Q3 2024.